Pharvaris Announces Annual General Meeting of Shareholders
Stocks in this Quantisnow insightHealth Care
Historical context for PHVS
Across the 17 sessions after earlier PHVS headlines, the stock closed higher 12 times and lower 5 times, with a median move of 2.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PHVS | SPY |
|---|---|---|---|
| May 29, 2026 | Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026 | +1.0% | +0.2% |
| May 13, 2026 | Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update | +5.4% | +0.6% |
| May 12, 2026 | Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares | +4.3% | -0.2% |
| May 8, 2026 | Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares | +1.4% | +0.8% |
| Apr 20, 2026 | Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference | +1.4% | -0.2% |
| Apr 9, 2026 | Wolfe Research initiated coverage on Pharvaris N.V. with a new price target | -1.8% | +0.6% |
Quantisnow market dataNASDAQ
PHVS
Pharvaris N.V.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for PHVS
Full PHVS profile on Quantisnow Follow PHVS and get a push notification the moment its next story breaks.